Investors seem increasingly jittery about the future prospects for COVID-19 vaccines.
Compare PFE Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Pfizer
Pfizer sells the leading COVID-19 vaccine -- and seven other blockbusters.
There are a couple of big reasons why Moderna stock isn't as good of a pick as Pfizer right now.
The short answer: Yes.
Both stocks have grabbed plenty of headlines over the past year.
This may determine whether booster rollout happens next week or not.
It has to do with the coronavirus -- but it's not about vaccines.
The market's caution when it comes to the healthcare sector presents a buying opportunity for these two solid businesses.
History says this month can be scary. These stocks can get you through it.